Cargando…

No inflammatory effects after acute inhalation of barium sulfate particles in human volunteers

BACKGROUND: Most threshold limit values are based on animal experiments. Often, the question remains whether these data reflect the situation in humans. As part of a series of investigations in our exposure lab, this study investigates whether the results on the inflammatory effects of particles tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Monsé, Christian, Westphal, Götz, Raulf, Monika, Jettkant, Birger, van Kampen, Vera, Kendzia, Benjamin, Schürmeyer, Leonie, Seifert, Christoph Edzard, Marek, Eike-Maximilian, Wiegand, Felicitas, Rosenkranz, Nina, Wegener, Christopher, Merget, Rolf, Brüning, Thomas, Bünger, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205122/
https://www.ncbi.nlm.nih.gov/pubmed/35710385
http://dx.doi.org/10.1186/s12890-022-02021-y
Descripción
Sumario:BACKGROUND: Most threshold limit values are based on animal experiments. Often, the question remains whether these data reflect the situation in humans. As part of a series of investigations in our exposure lab, this study investigates whether the results on the inflammatory effects of particles that have been demonstrated in animal models can be confirmed in acute inhalation studies in humans. Such studies have not been conducted so far for barium sulfate particles (BaSO(4)), a substance with very low solubility and without known substance-specific toxicity. Previous inhalation studies with zinc oxide (ZnO), which has a substance-specific toxicity, have shown local and systemic inflammatory respones. The design of these human ZnO inhalation studies was adopted for BaSO(4) to compare the effects of particles with known inflammatory activity and supposedly inert particles. For further comparison, in vitro investigations on inflammatory processes were carried out. METHODS: Sixteen healthy volunteers were exposed to filtered air and BaSO(4) particles (4.0 mg/m(3)) for two hours including one hour of ergometric cycling at moderate workload. Effect parameters were clinical signs, body temperature, and inflammatory markers in blood and induced sputum. In addition, particle-induced in vitro-chemotaxis of BaSO(4) was investigated with regard to mode of action and differences between in vivo and in vitro effects. RESULTS: No local or systemic clinical signs were observed after acute BaSO(4) inhalation and, in contrast to our previous human exposure studies with ZnO, no elevated values of biomarkers of inflammation were measured after the challenge. The in vitro chemotaxis induced by BaSO(4) particles was minimal and 15-fold lower compared to ZnO. CONCLUSION: The results of this study indicate that BaSO(4) as a representative of granular biopersistent particles without specific toxicity does not induce inflammatory effects in humans after acute inhalation. Moreover, the in vitro data fit in with these in vivo results. Despite the careful and complex investigations, limitations must be admitted because the number of local effect parameters were limited and chronic toxicity could not be studied. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12890-022-02021-y.